Anesthesia And Respiratory Devices Market Report 2026

Anesthesia And Respiratory Devices Market Overview

• Anesthesia And Respiratory Devices market size has reached to $37.63 billion in 2025 • Expected to grow to $70.71 billion in 2030 at a compound annual growth rate (CAGR) of 13.6% • Growth Driver: Rising Respiratory Diseases Rates Fuel Surge In Demand For Anesthesia And Respiratory Devices • Market Trend: Clinical Innovation With The U.S. Launch Of Its Atlan Anesthesia Workstation Family • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Anesthesia And Respiratory Devices Market?

Anesthesia and respiratory devices are used in the diagnosis and treatment of respiratory diseases. This market includes respiratory devices that are used to provide medication for medical conditions such as asthma, cystic fibrosis, acute respiratory distress syndrome, and others. The main types of anesthesia and respiratory devices are respiratory devices and equipment (therapeutic and diagnostic), anesthesia machines, anesthesia disposables, and respiratory disposables. The respiratory disposables are designed to be discarded after excessive breathing resistance, sorbent exhaustion, physical damage, or end-of-service life renders them unsuitable for use. The type of expenditure is public and private and the products used are instruments/equipment and disposables by various genders such as male and female and used in multiple end-users including hospitals and clinics, diagnostic laboratories, and others.

What Is The Anesthesia And Respiratory Devices Market Growth Forecast?

The anesthesia and respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $70.71 billion in 2030 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory care, rising investments in smart hospital technologies, growing demand for minimally invasive anesthesia delivery, expansion of remote patient monitoring solutions, increasing focus on personalized respiratory therapies. Major trends in the forecast period include increasing adoption of connected respiratory monitoring devices, rising demand for portable and home-based respiratory equipment, growing integration of smart anesthesia delivery systems, expansion of single-use respiratory disposables, enhanced focus on patient safety and infection control.

Global Anesthesia And Respiratory Devices Market Segmentation

1) By Type: Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables 2) By Type Of Expenditure: Public, Private 3) By Category: Instruments Or Equipment, Disposables 4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users Subsegments: 1) By Respiratory Devices And Equipment (Therapeutic And Diagnostic): Therapeutic Devices (Oxygen Therapy Devices, CPAP Or BiPAP Machines), Diagnostic Devices (Spirometers, Pulse Oximeters, Peak Flow Meters), Nebulizers 2) By Anesthesia Machines: Continuous Flow Anesthesia Machines, Portable Anesthesia Machines, Anesthesia Workstations 3) By Anesthesia Disposables: Anesthesia Masks, Endotracheal Tubes, Laryngeal Mask Airways (LMAs), Breathing Circuits 4) By Respiratory Disposables: Oxygen Masks, Ventilator Circuits, Filters And HME (Heat And Moisture Exchangers), Suction Catheters

What Are The Drivers Of The Anesthesia And Respiratory Devices Market?

The increased prevalence of respiratory diseases is expected to drive the growth of the anesthesia and respiratory devices market. Respiratory disease refers to medical conditions that interfere with breathing and gas exchange by affecting the organs and tissues of the lungs and airway systems. Anesthesia and respiratory equipment are integral to the treatment of respiratory diseases such as tuberculosis by facilitating necessary medical procedures, ensuring patient comfort and safety, and aiding in the monitoring and management of the disease. For instance, in June 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, emergency admissions for respiratory disease in England rose by 7% from the financial year ending 2023 to 2024, with COPD cases increasing by 9%, adult asthma by 17%, and pneumonia by 16% over the same period. Therefore, the increased prevalence of respiratory diseases will propel the growth of the anesthesia and respiratory devices industry going forward. Increasing healthcare expenditures are anticipated to propel the growth of the anesthesia and respiratory devices market. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. With the escalation of healthcare expenditures, there is typically a heightened emphasis on delivering superior healthcare services, encompassing surgical and respiratory care, thus generating a demand for cutting-edge devices that have the potential to enhance patient outcomes. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), the US-based federal agency, National Health Expenditure (NHE) grew 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures grew 10.4% to $1,519.7 billion in 2023, faster than the 3.2% growth in 2022. Therefore, increasing healthcare expenditure will drive the growth of the anesthesia and respiratory devices industry going forward.

Key Players In The Global Anesthesia And Respiratory Devices Market

Major companies operating in the anesthesia and respiratory devices market are Drägerwerk AG & Co KGaA, GE Healthcare, Koninklijke Philips N V, Medtronic plc, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical plc, Masimo Corporation, B Braun Melsungen AG, Shenzhen Mindray Bio‑Medical Electronics Co Ltd, Hamilton Medical AG, Nihon Kohden Corporation, Ambu A S, Invacare Corporation, SunMed Medical, Intersurgical Ltd, PARI GmbH, Heinen + Löwenstein GmbH & Co KG, Aerogen Ltd, DeVilbiss Healthcare LLC

Global Anesthesia And Respiratory Devices Market Trends and Insights

Major companies operating in the anesthesia and respiratory devices market are focusing on developing advanced solutions such as low- and minimal-flow anesthesia optimization to enhance patient safety and operational efficiency. Low and minimal flow anesthesia optimization is an approach that reduces anesthetic agent consumption by recycling sampled breathing gas and maintaining efficient delivery in real time, which helps hospitals lower costs and minimize environmental impact. For instance, in September 2023, Dräger, a Germany-based medical and safety technology products company, launched the Atlan anesthesia workstation family featuring a precision ventilation system and extensive safety functions for intraoperative care. The platform delivers safe and precise ventilation for neonates through adults and offers tailored workstation configurations with scalable options. It supports efficient hygiene routines with quick disassembly of ventilation components and smooth surfaces designed for easy cleaning. It integrates with Dräger Connect to provide visibility into clinical and operational metrics and helps hospitals improve care quality and resource management.

Regional Outlook

Asia-Pacific was the largest region in the global anesthesia and respiratory devices market in 2025. North America was the second largest region in the global anesthesia and respiratory devices market. Eastern Europe was the smallest region in the global anesthesia and respiratory devices market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Anesthesia And Respiratory Devices Market?

The anesthesia and respiratory devices market consists of sales of instruments such as resuscitators, laryngoscopes, flexible intubation scopes, supraglottic airways, ventilator circuits, HME, and other anesthesia and respiratory instruments that are used for the diagnosis and treatment of respiratory diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.